Acomo (ACOMO) Q3 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 TU earnings summary
22 Oct, 2026Executive summary
Q3 2026 sales were €352.5 million, down 1% YoY reported and 2% at constant currency; performance was in line with expectations, with four of five segments growing.
Financial highlights
YTD 2026 sales were €1,063.2 million, down 5% YoY reported and 3% at constant currency.
Outlook and guidance
Confidence in mid-term ambitions remains despite a turbulent macro environment; relationship-driven sourcing, operational initiatives and targeted acquisitions support the strategy.
A new US juice production facility is expected to become operational in Q1 2027 as production is brought in-house.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Acomo
- Second-best H1 ever, resilient margins, strong segment recovery, and positive outlook.ACOMO
H1 2026 - Q1 2025 sales up 16% to €388.8M, driven by Organic Ingredients and Spices & Nuts growth.ACOMO
Q1 2025 TU - Q1 2026 sales were resilient, led by Spices & Nuts growth and a rebound in Edible Seeds.ACOMO
Q1 2026 TU - Record results driven by strong segment growth, with sustainability and normalization ahead.ACOMO
H2 2025 - Q3 sales up 6% to €357.3M, led by Spices, Nuts, and Organic Ingredients; US remains challenging.ACOMO
Q3 2025 TU - Record sales and profit growth in H1 2025, led by Spices & Nuts and Organic Ingredients.ACOMO
H1 2025 - EBITDA fell 9% as cocoa volatility offset record Spices & Nuts growth; dividend held at €0.40.ACOMO
H1 2024 - Aims for €2B sales and 9% EBITDA margin via growth in plant-based, value-added ingredients.ACOMO
CMD 2025 - Record profit and EBITDA growth, strong H2, and major sustainability gains achieved.ACOMO
H2 2024